First, the entire premise—that Schedule I status is the primary obstacle to research—is flat-out wrong.

Paul Lee Corbett is facing a potential prison sentence of five years for possession of psilocybin mushrooms.

There’s a beauty and sense of wonder that comes from knowing how the world works, and the nature of the psychedelic experience dovetails almost perfectly with that awareness.

“Did you ever pick mushrooms off of cow poop when you were biking in Hawaii?” I ask her. “Actually, yes,” she admitted. I take advantage of the ease at which a conversation like this flows with my mom.

I chose to learn Grof’s methods for working therapeutically with LSD and use them in my private life to systematically explore my own mind and the mind of the universe as deeply as possible—73 high-dose sessions over 20 years.

There is an urgent need for cultural humility in psychedelic science in order to prevent it from falling into the same limiting, and often unethical, traps that we see in Western science and medicine.

MDMA-assisted psychotherapy gave me the ability to feel compassion and empathy for myself.

Renaming adverse effects of psychedelic drugs as “challenging experiences” minimizes, almost trivializes, their negative effects.

As a teenager, I was taking ten milligrams of Ritalin daily. Later, I grew to love the way these pills made it easier for me not to eat.

I came to a working hypothesis: at the center of the mystical experience is awe, wherein one is in the presence of something so great, so large, that it requires they completely reorder their mental structures - completely change the way they view reality.